Document Type : Case Reports

Authors

1 Dept. of Pathology, Loghman Hakim Hospital, Shahid Beheshti University of Medical Sciences, Tehran, Iran

2 Chronic respiratory Diseases Research Center, NRITLD, Shahid Beheshti University of Medical Sciences, Tehran, Iran

10.7508/ijp.2015.03.010

Abstract

Ollier’s syndrome, a variant of multiple enchondromatosis, is a rare disease with an estimated prevalence of 1/100,000, characterized by multiple enchondromas, asymmetrically involving small bones of the hands and feet, especially the proximal phalanges. Intracranial enchondromas, such as those arising from the skull base are extremely rare. Herein, we report a 25-year-old female, known case of Ollier’s disease, presenting with right eyelid ptosis and visual disturbance. Brain MRI revealed a skull base tumour suspicious to enchondroma followed by trans-sphenoidal resection. Histologic examination of the excisional biopsy sample confirmed the diagnosis of enchondroma.   How to cite this article: Sabeti S, Yousefi F, Pourabdollah Toutkaboni M. Enchondroma of the Skull Base in a Case of Ollier’s Syndrome. Iran J Pathol. 2015;10(3):237-42.

Keywords

Introduction

Enchondromas are common intraosseous benign cartilaginous tumours. When multiple, the condition called enchondromatosis, including Ollier disease and Maffuchi syndrome (1), with a tendency to involve ends of long bones and flat bones, frequently presenting in the first decade of life (2,3).

Intracranial chondromas are very rare tumours (4, 5), most frequent at the skull base with a predilection for the sphenoethmoidal region (6) and less commonly involving the dura mater, choroid plexus, leptomeninges and brain parenchyma (7). They occasionally have been reported to arise at the sites of previous trauma (8).

Case Report

A 25-year-old female patient, with known case of ollier’s syndrome of a history of multiple asymmetrical enchondromas (Fig. 1) associated with pelvic, tibial and femoral fractures during a period of 20 years, was admitted to our hospital with the chief complaint of right eyelid ptosis, progressive visual disturbance and bitemporal hemianopia, associated with marked deformation of the upper and lower extremities. She denied family history of similar disorder. She was alert and did not have history of headache, seizure attack or unconsciousness. No evidence of hemangioma was identified on detailed physical examination. All laboratory data were within normal limits.

Brain MRI revealed a lobulated heterogeneous mass measuring 34x26x23mm, located at pre-pontine cistern extending to suprasellar, right parasellar and right cerebellopontine angle and compressing the right optic nerve. Another small mass with similar characteristics was noted in left cerebellopontine angle. The masses showed low intensity signals on T1 (Fig. 2A), foci of hyperintensity on T2 (Fig. 2B) and contrast enhancement with a hypodense central core (Fig. 3). She then underwent trans-sphenoidal tumour excision.

Microscopic examination of the resection specimen showed multiple well delineated cartilaginous lobules without myxoid change separated by normal marrow fat and host lamellar bone (Fig. 4). Most parts of the tumor composed of evenly distributed chondrocytes with bland looking features devoid of mitoses. Another notable finding was focally increased cellularity accompanied with mild cellular atypia (Figs. 5 A&B). No entrapment of the host lamellar bone in the neoplasm was identified on serial sections. With regard to the radiologic, clinical and histopathologic findings, the case was diagnosed as skull base enchondroma. 

Plain radiograph of both hands revealing multiple enchondromas with calcification

Fig.1: Plain radiograph of both hands revealing multiple enchondromas with calcification

Fig.2: Brain MRI depicting lobulated intracranial mass in prepontine cistern involving the clivus, diagnosed as enchondroma, hypointense on T-1 weighted images (A) and depicting foci of hyperintensity on T-2 weighted images (B)

Fig.2: Brain MRI depicting lobulated intracranial mass in prepontine cistern involving the clivus, diagnosed as enchondroma, hypointense on T-1 weighted images (A) and depicting foci of hyperintensity on T-2 weighted images (B)

Coronal brain MRI showing marked contrast enhancement of Tumor

Fig.3: Coronal brain MRI showing marked contrast enhancement of Tumor

Cartilaginous neoplasm consistent with enchondroma. Note well-demarcation and absence of bone invasion (40X)

Fig. 4: Cartilaginous neoplasm consistent with enchondroma. Note well-demarcation and absence of bone invasion (40X)

Focal hypercellularity and mild nuclear atypia of enchondroma (100×, A) & (400×, B). These findings are common in Ollier’s syndrome and have no significance

Fig. 5: Focal hypercellularity and mild nuclear atypia of enchondroma (100×, A) & (400×, B). These findings are common in Ollier’s syndrome and have no significance

Discussion

Intracranial chondromas are benign rare cartilaginous tumors accounting for about 0.2% to 0.3% of all intracranial tumors (4, 5). They may develop at any age, most frequently observed in the third decade (9). Despite of purported lack of sex predilection, a slight female predominance is evident in several case reports (10). The first reported case of intracranial chondroma was described by Hirschfield in 1851 (11).

These neoplasms are usually solitary, but they have also been reported as a component of Ollier’s multiple chondromatosis (12) and Maffuci syndrome (13).

Intracranial chondromas mainly involve the skull base, with special tendency to the sellar and parasellar regions (14-16). Dura, brain parenchyma and intraventricular space (8, 9, 17) are other reported sites of origin.

Various origins have been proposed for intracranial chondromas, the most common one being embryonic remnants of chondrogenic cells along the synchondrosis of the skull base (18). The chondromas arising from the dura matter, choroid plexus, and cerebral cortex have been assumed to arise from metaplasia of meningeal and perivascular fibroblasts (19). Proliferation of ectopic embryologic rests of cartilaginous cells, traumatic displacement of cartilaginous elements or stimulation of fibroblasts to cartilaginous metaplasia by inflammatory processes are other proposed theories for the development of intracranial chondromas (18).

The slow growth of these tumors result in delayed clinical presentation, late diagnosis and large tumor size at the time of detection. Clinical manifestations are nonspecific, usually depend on tumor location and include headaches (8), proptosis, diplopia and varying degrees of visual acuity impairment as a result of orbital extension (15) forgetfulness and lack of concentration (18), Generalized tonic–clonic seizures (4), neurological deficits such as ptosis and bilateral hemianopia, increased intracranial pressure and psychologic/personality disorders. As we discussed above, our case had visual acuity impairment, bitemporal hemianopia and eyelid ptosis which progressed slowly.

Radiologic manifestations of the tumor are nonspecific and despite of developments, the definite diagnosis is histopathologic.

The histopathology of the biopsy samples of multiple enchondromatosis cases usually shows hypercellularity, double nucleated cells and nuclear hyperchromasia, suggesting a diagnosis of low-grade chondrosarcoma that should be ignored in the absence of clinical/radiologic features of chondrosarcoma (2). In current case, focal tumoral hypercellularity and mild nuclear atypia was ignored due to patient proved Ollier`s disease as well as correlation with other histological and radiological data.

Radiologically, the tumor has been classified into two types: Type 1, which is the classic and more common type with homogenous and isodense pattern or mixed density with minimal to moderate enhancements and type 2 with hypodense cystic central area on CT scan (20). The most common differential diagnosis is meningioma, which is almost indistinguishable by radiology. Tanohata et al. reported two skull base chondromas that exhibited delayed contrast enhancement on CT after administration of a high-dose of contrast medium. They suggested this CT feature to be of help in the differentiation of intracranial chondromas from meningiomas and neurinomas (21). MRI shows a well-circumscribed lesion without accompanying tissue edema that exhibits heterogeneous signal with intermediate to low intensity on T1-weighted images and mixed intensity on T2-weighted images (5).

The main complication of enchondromatosis is the risk of transformation to chondrosarcoma (22, 23) with an estimated risk of 20 to 50% (22). Histopathologic diagnosis of transformed chondrosarcoma may be difficult and in these instances, clinicoradiologic correlation is recommended (23). Any cortical bone destruction or extension in to the haversian systems or soft tissue favours chondrosarcoma.

In addition to the risk of developing chondrosarcoma, Ollier patients also have an increased risk of non-skeletal malignancies, especially glial tumours (24, 25).

Treatment of intracranial enchondroma is complete surgical removal, and the long-term prognosis is good. Local invasion or recurrence should raise the possibility of transformation to chondrosarcoma (9, 26).

Conclusion

Concluding from the above discussion, intracranial chondromas are well-differentiated cartilaginous neoplasms with a small proclivity for sarcomatous tansformation.

Our case was valued because of its rarity, confusing and misleading histopathologic features and presentation in the background of a rare syndrome (Ollier syndrome); and indicates that histopathologic features of a bone neoplasm may be misleading if not accompanied by clinical and radiologic findings.

Conflict of interest

All authors declare there is no conflict of interests.

How to cite this article:
Sabeti S, Yousefi F, Pourabdollah Toutkaboni M. Enchondroma of the Skull Base in a Case of Ollier’s Syndrome. Iran J Pathol. 2015;10(3):237-42.

  1. Silve C, Juppner H. Ollier disease. Orphanet J Rare Dis 2006;1(1):37.
  2. Mills SE, Carter D, Greenson JK, Reuter VE, Stoler MH. Sternberg's Diagnostic Surgical Pathology, vol. 1. 5th ed. Philadelphia: Lippincott, Williams & Wilkins; 2009.
  3. Shaheen F, Ahmad N, Gojwari T, Teli M.A, Resold R, Singh M. Multiple Enchondromatosis: Ollier’s Disease. JK SCIENCE 2010;12(4):207-9.
  4. Colpan E, Attar A, Erekul S, Arasil E. Convexity dural chondroma: a case report and review of the literature. J Clin Neurosci 2003;10(1):106-8.
  5. Delgado-López PD, Martín-Velasco V, Galacho-Harriero AM, Castilla-Díez JM,                                                   Rodríguez-Salazary A, Echevarría-Iturbe C. Large chondroma of the dural convexity in a patient with Noonan’s syndrome. Case report and review of the literature. Neurocirugía 2007;18(3):241-6.
  6. Li TC, Chen Y, Lin SM, Tseng SH. Chondroma of the Falx — Case Report. Tzu Chi Med J 2005;17(4):269-72.
  7. Kurt E, Beute GN, Sluzewski M, van Rooij WJ, Teepen JL. Giant chondroma of the falx. Case report and review of the literature. J Neurosurg 1996;85(6):1161-4.
  8. Brownlee RD, Sevick RJ, Rewcastle NB, Tranmer BI. Radiologic-Pathologic Correlation Intracranial Chondroma. AJNR 1997;18(5):889-93.
  9. De Coene B, Gilliam C, Grandin C, Nisolle JF, Trigaux JP, Landou JB. Unusual location of an intracranial chondroma. AJNR Am J Neuroradiol 1997;18(3):573-5.
  10. Krayenbühl H, Yasargil M: Chondromas. Prog Neurol Surg 1978;6:435–463.
  11. Nakayama M, Nagayama T, Hirano H, Oyoshi T, Kuratsu J. Giant chondroma arising from the dura mater of the convexity. Case report and review of the literature. J Neurosurg 2001;94:331–334.
  12. Traflet RF, Babaria AR, Barolat G, Doan HT, Gonzalez C, Mishkin MM. Intracranial chondroma in a patient with Ollier's disease. Case report. J Neurosurg 1989;70(2):274-6.
  13. Chakrabortty S, Tamaki N, Kondoh T, Kojima N, Kamikawa H, Matsumoto S. Maffucci's syndrome associated with intracranial enchondroma and aneurysm: case report. Surg Neurol 1991;36(3):216-20.
  14. Munemitsu H, Matusda M, Hirai O, Fukumitsu T, Kawamura J. Intrasellar chondroma. Neurol Med Chir (Tokyo) 1981;21(7):775–780.
  15. Sarwar M, Swischuk LE, Schecter MM. Intracranial chondromas. AJR Am J Roentgenol 1976;127(6):973–7.
  16. Miki K, Kawamoto K, Kawamura Y, Matsumura H, Asada Y and Hamada A. A rare case of Maffucci's syndrome combined with tuberculum sellae enchondroma, pituitary adenoma and thyroid adenoma. Acta Neurochirurgica 1987;87(1-2):79-85.
  17. 1. Faraji M, Ashrafzadeh F, Baharvahdat H. Intradural Chondroma: A case report and literature review. Arch Iranian Med. 2004;7:61-5.
  18.  Zhan RY, Pan XF, Wan S, Lan P, Zhang YC, Weng NC, et al. Solitary intracerebral chondroma without meningeal attachment: a case report with review of the literature. J Int Med Res 2011;39(2):675–681.
  19. Nakazawa T, Inoue T, Suzuki F, Nakasu S, Handa J. Solitary intracranial chondroma of the convexity dura: case report. Surg Neurol 1993;40(6):495–498.
  20. Lacerte D, Gagné F, Copty M. Intracranial chondroma. Report of two cases and review of the literature. Can J Neurol Sci 1996;23(2):132-7.
  21. Tanohata K, Maehara T, Aida N, Unimo S, Matsui K, Mochimatsu Y, Fujitsu K. Computed tomography of intracranial chondroma with emphasis on delayed contrast enhancement. J Comput Assist Tomogr 1987;11(5):820–823.
  22. Climent Alcala FJ, Guerrero-Fernandez J, Melcon CC, Gonzalez CI, Carceller BF, Gracia BR. Intrasellar enchondroma in female child with Ollier disease (in Spanish with English abstract). An Pediatr (Barc) 2009;71(6):582-4.
  23. Erol B, Tetik C, Sirin E, Kocaoglu B, Bezer M. Surgical treatment of hand deformities in multiple enchondromatosis: a case report (in Turkish with English abstract). Acta Orthop Traumatol Turc 2006;40(1):89-93.
  24. Van Nielen KMB, and De Jong BM. A case of Ollier’s disease associated with two intracerebral low-grade gliomas. Clin Neurol Neurosurg 1999;101(2):106-110.
  25.  Pansuriya TC, Kroon HM, Bovee J VMG. Enchondromatosis: insights on the different subtypes. Int J Clin Exp Pathol 2010;3(6):557-69.
  26. Pelz D, Alotaibi NM, Mansouri A, Carvalho FG, Balogun JA, Gentili F. Chondrosarcoma of the Skull Base in Ollier's Disease. Canadian J Neurol Sci 2014;41(1):86-87.